Xinlin F. Liu
Jinan, 250022, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
Echocardiographic diagnosis of cardiac thrombosis in children with Mycoplasma pneumoniae pneumonia: a clinical case series
Journal: Zhonghua xin xue guan bing za zhi
Published: July 15, 2026
Antibody-oligonucleotide conjugates: design principles, intracellular delivery, and translational opportunities.
Journal: Journal of hematology & oncology
Published: April 20, 2026
Sex as a Contextual Modifier in Colorectal Cancer: Integrating Tumor Sidedness, Molecular Subtype, Immune Ecology, and Early-Onset Disease.
Journal: Cancers
Published: March 30, 2026
Agonistic bispecific antibodies: an emerging frontier in antibody therapeutics.
Journal: Journal of translational medicine
Published: March 25, 2026
Advanced platforms for antibody delivery: Overcoming biological barriers and improving therapeutic performance.
Journal: International immunopharmacology
Published: March 15, 2026
AIE Gemini Surfactant-Enabled Janus Membrane for All-In-One "Sampling-Detection-Elimination" of Airborne Pathogens.
Journal: Environmental science & technology
Published: March 03, 2026
Trispecific antibodies in cancer therapy: Mechanisms, clinical progress and future directions.
Journal: International immunopharmacology
Published: January 03, 2026
Prussian blue-supported platinum nanoparticles as pH-Universal catalase mimics: enabling robust chemiluminescent immunoassay for VEGF in clinical diagnostics.
Journal: Frontiers in bioengineering and biotechnology
Published: December 08, 2025
Antibody-based targeted protein degradation: Mechanisms, challenges and future directions.
Journal: International journal of biological macromolecules
Published: September 24, 2025
Harnessing IgM for solid tumor therapy: biology, engineering advances, and translational challenges.
Harnessing IgM for solid tumor therapy: biology, engineering advances, and translational challenges.
Journal: Frontiers in immunology
Published: September 24, 2025
Engineering HER2-targeted biparatopic antibodies to promote receptor internalization and restore antitumor efficacy.
Journal: Frontiers in immunology
Published: September 23, 2025
Biparatopic HER2-targeted nanobody binder synergizes with trastuzumab in resistant tumor cells.
Journal: Frontiers in immunology
Published: September 23, 2025
Last Updated: 09/26/2026